Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells

International Journal of Cancer

Volumn 94, Issue 2, 2001, Pages 257-267

  Terao, Yasuhisa ^a   Nishida, Jun Ichi ^a   Horiuchi, Shinji ^a   Rong, Fengnian ^a   Ueoka, Yousuke ^a   Matsuda, Takao ^a   Kato, Hidenori ^a   Furugen, Yoshiaki ^a   Yoshida, Koyo ^a   Kato, Kiyoko ^a   Wake, Norio ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

P16; P21; P53; PRb; Senescence; Sodium butyrate

Indexed keywords

BUTYRIC ACID; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL AGING; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UTERINE CERVIX CANCER;

ANIMALS; BUTYRATES; CELL AGING; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MICE; MICE, INBRED BALB C; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0035888083     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1448     Document Type: Article

References (42)

1. Short chain fatty acids in human large intestine, portal, hepatic and venous blood
2. Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in prevention of large-bowel cancer
3. Sodium butyrate inhibits histone deacetylation in cultured cells
4. Cellular growth state differentially regulates enterocyte gene expreession in butyrate-treated HT-29 cells
5. 5′-Flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells
6. Direct inhibition of the expression of cyclin D1 gene by sodium butyrate
7. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line
8. Butyrate blocks the accumulation of CDC2 mRNA in late G1 phase but inhibits both the early and late G1 progression in chemically transformed mouse fibroblasts BP-A31
9. Inhibition of cell cycle progression by sodium butyrate in normal rat kidney fibroblasts is altered by expression of the adenovirus 5 early 1A gene
10. Induction of p21 (WAF-1/CIP1) during differentiation
11. Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism
12. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells
13. WAF1, a potential mediator of p53 tumor suppression
14. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts
15. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and pl6INK4a
16. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts
17. Senescence of human fibroblasts induced by oncogenic Raf
18. Genetic analysis of indefinite division in human cells: Identification of four complementation groups
19. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
20. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerace inhibition
21. Induction of senescence in human malignant glioma cells by pl6INK4A
22. Overexpression of the p21sdil gene induces senescence-like state in human cancer cells. Implication for senescence-directed molecular therapy for cancer
23. Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs
24. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents
25. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
26. Role of the Rb-mediated cell cycle regulatory pathway in human ovarian cancer cell lines
27. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases
28. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells
29. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts
30. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product
31. Effects of p21cip/waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication
32. Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells
33. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo
34. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals
35. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells
36. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition
37. Distinct roles for cyclin-dependent kinases in cell cycle control
38. Inhibitors Of mammalian G1 cyclin-dependent kinases
39. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit
40. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts
41. Altered expression Of plasminogen activator and plasminogen activator inhibitor during cellular senescence
42. Efficient transfer of genes into senescence cells by adenovirus vectors via highly expressed alpha v beta 5 integrin